These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36097672)

  • 1. Comparative effectiveness of calfactant and beractant in neonatal respiratory distress syndrome: A systemic review and meta-analysis.
    Haider S; Azhar N; Zahid M; Iqbal K; Shoaib N; Irshad N; Siddiqui AS; Ahmed J
    Pediatr Pulmonol; 2022 Dec; 57(12):2928-2936. PubMed ID: 36097672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of surfactant preparations in premature infants.
    Trembath A; Hornik CP; Clark R; Smith PB; Daniels J; Laughon M;
    J Pediatr; 2013 Oct; 163(4):955-60.e1. PubMed ID: 23769501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calfactant: a review of its use in neonatal respiratory distress syndrome.
    Onrust SV; Dooley M; Goa KL
    Paediatr Drugs; 1999; 1(3):219-43. PubMed ID: 10937453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants.
    Singh N; Halliday HL; Stevens TP; Suresh G; Soll R; Rojas-Reyes MX
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010249. PubMed ID: 26690260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of porcine versus bovine surfactants for preterm newborns with respiratory distress syndrome: systematic review and meta-analysis.
    Singh N; Hawley KL; Viswanathan K
    Pediatrics; 2011 Dec; 128(6):e1588-95. PubMed ID: 22123870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study.
    Ramanathan R; Bhatia JJ; Sekar K; Ernst FR
    J Perinatol; 2013 Feb; 33(2):119-25. PubMed ID: 21886094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
    Jeon GW; Oh M; Sin JB
    Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
    Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
    Bahadue FL; Soll R
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD001456. PubMed ID: 23152207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural vs synthetic surfactants in neonatal respiratory distress syndrome.
    Halliday HL
    Drugs; 1996 Feb; 51(2):226-37. PubMed ID: 8808165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choosing a right surfactant for respiratory distress syndrome treatment.
    Ramanathan R
    Neonatology; 2009; 95(1):1-5. PubMed ID: 18832858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
    Ardell S; Pfister RH; Soll R
    Cochrane Database Syst Rev; 2015 Aug; 8(8):CD000144. PubMed ID: 26301526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
    Ardell S; Pfister RH; Soll R
    Cochrane Database Syst Rev; 2015 May; (5):CD000144. PubMed ID: 26009996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of pulmonary surfactant in respiratory distress syndrome in preterm infants: a Bayesian network meta-analysis.
    Qiu C; Ma C; Fan N; Zhang X; Zheng G
    Arch Med Sci; 2023; 19(5):1446-1453. PubMed ID: 37732036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal derived surfactant extract for treatment of respiratory distress syndrome.
    Seger N; Soll R
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of beractant and calfactant in a neonatal intensive care unit.
    Hastings LK; Renfro WH; Sharma R
    Am J Health Syst Pharm; 2004 Feb; 61(3):257-60. PubMed ID: 14986555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Three Different Administration Positions for Intratracheal Beractant in Preterm Newborns with Respiratory Distress Syndrome.
    Karadag A; Ozdemir R; Degirmencioglu H; Uras N; Dilmen U; Bilgili G; Erdeve O; Cakir U; Atasay B
    Pediatr Neonatol; 2016 Apr; 57(2):105-12. PubMed ID: 26190853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of surfactant administration via thin catheter in preterm infants with neonatal respiratory distress syndrome: A systematic review and meta-analysis.
    Wu X; Feng Z; Kong J; Lai Y; Jia C; Xu Z; Wu F; Cui Q; Chen Y
    Pediatr Pulmonol; 2021 Sep; 56(9):3013-3025. PubMed ID: 34215018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In response to mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study.
    Egan EA
    J Perinatol; 2013 Feb; 33(2):165-6. PubMed ID: 23361501
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.
    Soll RF; Blanco F
    Cochrane Database Syst Rev; 2001; (2):CD000144. PubMed ID: 11405951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.